Global /South Korea /Healthcare /Drug Manufacturers - General /000100
chevron_leftBack
Yuhan Corp. logo

Yuhan Corp.

000100
KRX: 000100 Delayed
91,800KRW -1.5%
59.89 USD
As of 5 June 2026, Yuhan Corp. has a market cap of $4.51B USD, ranking #4102 globally and #102 in South Korea. It ranks #310 in the Healthcare sector, and #118 in the Drug Manufacturers - General industry.
Global Rank
4102
Country Rank
102
Sector Rank
310
Industry Rank
118
Key Stats
Market Cap
$4.51BUSD
6.92T KRW
Enterprise Value
$4.53BUSD
6.94T KRW
Revenue (TTM)
$1.43BUSD
2.19T KRW
EBITDA (TTM)
$113.82MUSD
174.47B KRW
Net Income (TTM)
$126.62MUSD
194.08B KRW
EBITDA Margin
8%
Profit Margin
8.9%
PE Ratio
35.9
Forward PE
43.2
PS Ratio
3.2
PB Ratio
2.9
EV/EBITDA
23.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Wook-Je Cho open_in_new
Employees
2,067
Founded
1926
Website
yuhan.co.kr open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.5% -1.9% -7.1% -15% -22% -17%

News

Loading...

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
000100
(주)유한양행
ISIN: KR7000100008
Shares Out.:
73.616M1 Shares Float: 52.211M2
TV:
SA:
YF:
GF:
BA:
MS:
91,800 KRW
Korea Exchange
MIC: XKRX
000105
(주)유한양행 Pfd Registered Shs Non-Voting
ISIN: KR7000101006
TV:
SA:
YF:
GF:
BA:
MS:
87,700 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Yuhan Corp.

Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and analytical method development and regulatory support. The company also provides APIs and intermediates, including antibiotic, anti-thrombotic, anti-hyperlipidemics, and anti-hypertensive; and custom synthesis services through commercial supply in areas of anti-viral, anti-HIV, anti-HCV, anti-biotic, antihistamine, anti-diabetic, ß-lactamase inhibitor, CNS intermediate, PEG-compounds, and others. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)
Name
Market Cap diff.
PE
$9.07B
13.91T KRW
101%
-
$6.72B
10.3T KRW
49%
1958.1
$5.2B
7.97T KRW
15%
29.9
298380
$4.92B
7.55T KRW
9.1%
-
$4.41B
6.76T KRW
-2.3%
-
$4.0B
6.12T KRW
-12%
36.1
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
17K%
38.1
JNJ
$547.28B
12K%
26.4
ABBV
$360.63B
8K%
97.4
$324.68B
256.25B CHF
7K%
19.9
AZN
$289.43B
215.59B GBP
6K%
27.6
NOVN
$277.35B
218.9B CHF
6K%
20.5
chevron_leftBack